Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Zanidatamab Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	BB (64)
Zanidatamab HER2 Low Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	BB (64)
Tucatinib Metastatic Neoplasm	QuantumLeap Healthcare Collaborative	P2	B (63)
Trastuzumab Duocarmazine Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (55)
Zanidatamab Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (55)
Abemaciclib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Abemaciclib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
arx788 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
arx788 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
arx788 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
ARX 788 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
ARX 788 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
ARX 788 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Capecitabine Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Capecitabine Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Carboplatin Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dan-222 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dan-222 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dan-222 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Datopotamab Deruxtecan Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Datopotamab Deruxtecan Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Datopotamab Deruxtecan Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dostarlimab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dostarlimab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Dostarlimab Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)

Showing 1 to 25 of 278 assets

PreviousPage 1 of 12Next